RxSight, Inc.
RXSTNASDAQHealthcare● Active
$4.95
$-0.05(-1.00%)
Market Cap$204913210
P/E Ratio—
52W High$16
52W Low$4.7
RxSight, Inc. (RXST) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RXST · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.13B | $0.14B | $0.09B | $0.05B | $0.02B |
| Cost of Revenue | $0.03B | $0.04B | $0.04B | $0.03B | $0.02B |
| Gross Profit | $0.10B | $0.10B | $0.05B | $0.02B | $0.00B |
| Gross Margin %(computed) | 76.60% | 70.71% | 60.36% | 43.52% | 19.99% |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.03B | $0.03B | $0.03B | $0.02B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.15B | $0.14B | $0.10B | $0.08B | $0.06B |
| Operating Income | ($0.05B) | ($0.04B) | ($0.05B) | ($0.06B) | ($0.05B) |
| Operating Margin %(computed) | -35.84% | -26.34% | -56.23% | -129.21% | -233.64% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | ($0.03B) | ($0.05B) | ($0.07B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.04B) | ($0.03B) | ($0.05B) | ($0.07B) | ($0.05B) |
| Net Margin %(computed) | -28.96% | -19.62% | -54.57% | -136.22% | -215.50% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.95 | $-0.71 | $-1.41 | $-2.41 | $-1.78 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.03B | 0.03B | 0.03B |
| EBITDA | ($0.04B) | ($0.02B) | ($0.04B) | ($0.06B) | ($0.04B) |
| EBITDA Margin %(computed) | -29.46% | -16.98% | -46.07% | -117.90% | -181.52% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more RxSight, Inc. data
About RxSight, Inc. (RXST) Income Statement
RxSight, Inc. (RXST) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RXST reported revenue of $0.13B, gross profit of $0.10B (gross margin 76.60%), and net income of ($0.04B) — a net profit margin of -28.96%.
Frequently asked questions
RXST · 4 questionsRxSight, Inc. (RXST) reported revenue of $0.13B for 2025, down 3.9% year-over-year.
RXST revenueRXST salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08